Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Respir Med. 2010 Feb;4(1):13-9.

Clinical use of sildenafil in pulmonary artery hypertension.

Author information

  • 1Prime Heart and Vascular Institute, Shivalik Hospital, Sector-69, Mohali, Punjab, India. tpsinghtp@yahoo.co.in

Abstract

Severe pulmonary hypertension is a debilitating disease with short life expectancy that often affects young people. It is usually idiopathic pulmonary artery hypertension and is characterized by progressive elevation of pulmonary artery pressure and vascular resistance, right ventricular failure and death with a limited median survival time. There is an imbalance in vasoconstrictive and vasodilatory substances. The phosphodiesterase-5 inhibitor sildenafil, a pulmonary and penile vasodilator initially approved for erectile dysfunction, is found to be efficacious in severe pulmonary artery hypertension. There are limited treatment options for the management of pulmonary artery hypertension in developing countries and sildenafil is a reasonable treatment option. This article reviews the relevant clinical data in pulmonary hypertension and the role of sildenafil in its management.

PMID:
20387288
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk